COH announces release of Nucleus Smart App for Android  
 
    S&P DJI Announces June Quarterly Rebalance  
 
    COH Hosts Investor Day 4 May 2018  
 
    Ceasing to be a substantial holder  
 
    Becoming a substantial holder  
 
    Amended Notice - Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Appendix 3Y - Dig Howitt  
 
    Appendix 3B  
 
    Ceasing to be a substantial holder  
 
    Ceasing to be a substantial holder  
 
    COH Half Year Results Analyst Presentation  
 
    COH Half Year Results Media Release 13.02.2018  
 
    Dividend/Distribution - COH  
 
    Half Year Accounts  
 
    Response to ASX query on Appendix 3Y  
 
    Appendix 3Z - Chris Smith  
 
    Change in substantial holding  
 
    Appendix 3Y - Chris Smith  
 
    Initial Director's Interest Notice  
 
    COH CEO Transition and Related Board Changes  
 
    Appendix 3B  
 
    Appendix 3B  
 
    COH 2017 AGM - Results of Meeting  
 
    2017 Chairman's AGM Address to Shareholders  
 
    2017 Cochlear AGM Presentation to Shareholders  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3Y - Alison Deans  
 
    Appendix 3B  
 
    AGM Proxy Form  
 
    Notice of Annual General Meeting  
 
    Appendix 3Y - Bruce Robinson  
 
    Appendix 3B  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Corrected - Appendix 3Y - Chris Smith  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 4G  
 
    COH 2017 Tax Contribution Report  
 
    COH 2017 Corporate Governance Statement  
 
    COH Investor Handbook Aug17  
 
    COH 2017 Annual Report  
 
    COH FY17 Result Presentation Slides  
 
    COH FY17 Result Announcement  
 
    Dividend/Distribution - COH  
 
    Appendix 4E  
 
    Director Appointment/Resignation  
 
    Change in substantial holding  
 
    COCHLEAR TO EXPAND GLOBAL CAPACITY  
 
    Ceasing to be a substantial holder  
 
    Becoming a substantial holder  
 
    Change in substantial holding  
 
    Cochlear acquires audiology practice management software  
 
    Cochlear Investor Day Presentations - Corrections  
 
    COH Hosts Investor Day 4 May 2017  
 
    Change in substantial holding  
 
    COH Half Year Report F17  
 
    Ceasing to be a substantial holder  
 
    COH Half Year Results Analyst Presentation  
 
    COH Half Year Results Media Release  
 
    Dividend/Distribution - COH  
 
    Half Yearly Report and Accounts  
 
    COH RESIGNATION & APPOINTMENT OF COMPANY SECRETARY  
 
    COH Announcement of New CFO  
 
    Becoming a substantial holder  
 
    Appendix 3B  
 
    Appendix 3X  
 
    Appointment of Prof Bruce Robinson as non-executive Director  
 
    Change in substantial holding  
 
    Decision in US Patent Infringement Case  
 
    Appendix 3B  
 
    Change of Director's Interest Notice - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    COH 2016 AGM - Results of Meeting  
 
    2016 Cochlear AGM Presentation to Shareholders  
 
    2016 Chairman's AGM Address to Shareholders  
 
    Becoming a substantial holder  
 
    Appendix 3B  
 
    Retirement of Chief Financial Officer  
 
    Voting Form  
 
    Notice of Annual General Meeting  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Appendix 3B  
 
    COH Investor Handbook  
 
    Dividend/Distribution - COH  
 
    COH 2016 Tax Contribution Report  
 
    Appendix 4G  
 
    COH 2016 Corporate Governance Statement  
 
    COH 2016 Annual Report  
 
    COH FY16 Result Presentation Slides  
 
    COH FY16 Result Announcement  
 
    Appendix 4E  
 
    COH Senior Executive Appointments  
 
    Becoming a substantial holder  
 
    Cochlear Hosts Investor Day 28 April 2016  
 
    Appendix 3B  
 
    Appendix 3Y - Rick Holliday-Smith  
 
    Half Year Report 2016  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Ceasing to be a substantial holder  
 
    Change in substantial holding  
 
    COH Half Year Results Analyst Presentation  
 
    COH Half Year Results Media Release 11.02.2016  
 
    Dividend/Distribution - COH  
 
    Half Year Report & Accounts  
 
    Appendix 3B  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3Y - Chris Smith  
 
    COH 2015 AGM - Results of Meeting  
 
    20/10/15 Cochlear AGM Presentation to Shareholders  
 
    20/10/15 Chairman's AGM Address to Shareholders  
 
    Appendix 3B - Cochlear Employee Share Plan  
 
    Form - Questions from Shareholders  
 
    Voting Form  
 
    Invitation letter from Chairman - AGM  
 
    Notice of Annual General Meeting  
 
    Appendix 3Y - Chris Smith  
 
    Appendix 3B  
 
    Change in substantial holding  
 
    Appendix 3X - Chris Smith  
 
    Appendix 3Z - Chris Roberts  
 
    Appendix 3B  
 
    Appendix 3B  
 
    CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES  
 
    Appendix 3Y - Chris Roberts  
 
    Appendix 3B  
 
    Appendix 3Y - Glen Boreham  
 
    Appendix 3Y - Dr Chris Roberts  
 
    Appendix 3Y - Rick Holliday-Smith  
 
    Dividend/Distribution - COH  
 
    Full Year Results Analyst Presentation  
 
    Full Year Statutory Accounts and Annual Report  
 
    Updated Trading Policy  
 
    COH Chris Smith Announced as Incoming CEO of Cochlear  
 
    Judgment in United States Patent Infringement Laws  
 
    DECISION IN US PATENT INFRINGEMENT CASE  
 
    Half Year Report 2015  
 
    Ceasing to be a substantial holder  
 
    Appendix 3Y - Alison Deans  
 
    Appendix 3Y - Chris Roberts  
 
    COH Half Year Results Analyst Presentation  
 
    COH Half Year Results Media Release 10.02.2015  
 
    Half Year Report & Accounts  
 
    Director Appointment  
 
    Director Appointment  
 
    COH 2014 AGM - Results of Meeting  
 
    Cochlear AGM Presentation to Shareholders  
   
    Chairman's AGM Address to Shareholders  
   
    COH Full Year Results Analyst Presentation 05.08.2014  
 
    COH Full Year Results Media Release 05.08.14  
 
    Preliminary Final Report and Full Year Statutory Accounts  
 
    COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP  
 
    Half Year Report 2014  
 
    FDA approves Cochlear Nucleus Hybrid for sale in USA  
 
    COH Half Year Results Analyst Presentaton  
 
    COH Half Year Results Media Release  
 
    Half Year Report & Accounts  
 
    COH Jury Trial Verdict on USA Patent Infringement Case  
 
    FDA Advisory panel votes favourably on Hybrid hearing device  
   
    Cochlear 2013 AGM - Results of Meeting  
   
    Cochlear AGM Presentation to Shareholders  
 
    Chairman's AGM Address to Shareholders  
 
    Full Year Results Analyst Presentation  
 
    Cochlear F'13 Full Year Results  
 
    Full Year Financial Statements 4E 30 June 2013  
 
    UBS Australian Healthcare Conference 2013 Presentation  
 
    Cochlear update on Nucleus 6 launch and trading conditions  
 
    F'13 Half Year Report  
 
    Half Year Results Analyst Presentation  
 
    Cochlear F'13 Half Year Results  
 
    Financial Statements  
 
    Cochlear 2012 AGM - Results of Meeting  
 
    Cochlear AGM Presentation to Shareholders  
 
    Chairman's AGM Address to Shareholders  
 
    Full Year Results Analyst Presentation  
 
    Update on Nucleus CI500 series implant recall  
 
    F'12 Full Year Results  
 
    Financial Statements  
 
    Cochlear to vigorously patent infringement complaint  
 
    F'12 Half Yearly Report  
 
    Half Year Results Analyst Presentation  
 
    F'12 Half Yearly Results  
 
    Financial Statements  
 
    Update on Nucleus CI500 Series Implant Recall  
 
    Cochlear 2011 AGM - Results of Voting  

 
    Cochlear AGM Presentation to Shareholders  

 
    Chairman`s AGM Address to Shareholders  

 
    Letter to Shareholders  
 
    Cochlear announces voluntary recall of Nucleus CI500 cochlear implant range  

 
    Full Year Results Analyst Presentation  

 
    F'11 Full Year Results  

 
    Financial Statements  

 
    Half Year Results Analyst Presentation  

 
    F' 11 Half Yearly Results  
 
    Half Year Report and Accounts  
 
    Cochlear 2010 AGM - Results of Meeting  
 
    Chairman`s AGM Address to Shareholders  
 
    Cochlear AGM Presentation to Shareholders  
 
    Full Year Results Analyst Presentation  
 
    F'10 Full Year Results  
 
    Financial Statements  
 
    Cochlear announces appointment of Non-Executive Director  
 
    Settlement Agreement with the DOJ and OIG  
 
    Cochlear Ltd Announces Appointment of New Chairman  
 
    F'10 Half Yearly Report  

 
    Half Year Results Analyst Presentation  

 
    F'10 Half Year Results  

 
    Financial Statements  

 
    Cochlear 2009 AGM Results of Voting  

 
    Cochlear AGM Presentation to Shareholders  

 
    Chairmans AGM Address to Shareholders  

 
    FDA Approval for Nucleus 5 System  
 
    Full Year Results Analyst Presentation  

 
    F'09 Full Year Results  

 
    Financial Statements  

 
    Cochlear Market Update  

 
    Cochlear completes debt refinancing  

 
    Conclusion of agreements for new global headquarters  

 
    F'09 Half Year Report  

 
    Half Year Results Analyst Presentation  

 
    F'09 Half Year Results  

 
    Financial Statements  

 
    Cochlear 2008 AGM Results of Meeting  

 
    Chairmans AGM Address to Shareholders  

 
    Cochlear AGM Presentation to Shareholders  

 
    Proxy Form  
 
    Chairman`s Letter to Shareholders  
 
    Notice of Annual General Meeting  
 
    Annual Report to shareholders - Financial  
 
    Annual Report to shareholders - Editorial  
 
    Full Year Results Analyst Presentation  

 
    F'08 Full Year Results  

 
    Financial Statements  
 
    F'08 Half Yearly Report  
 
    COH to Work with FDA to Resolve Issues in Warning Letter  
 
    Half Year Analyst Presentation  
 
    F'08 Half Yearly Report  
 
    Financial Statements  
 
    Cochlear to Vigorously Defend Patent Infringement Complaint  
 
    Cochlear 2006 AGM Results of Meeting  
 
    Cochlear's plans for new Sydney Global Headquarters  
 
    Chairman's AGM Address to Shareholders  
 
    Cochlear AGM Presentation to Shareholders  
 
    Full Year Results Analyst Presentation  
 
    Financial Statements  
 
    F'07 Full Year Results  
 
    F'07 Half Year Results Analyst Presentation  
 
    F'07 Half Year Results  
 
    Half Yearly Report & Half Year Accounts  
 
    Cochlear acquires key supplier's operations  
 
    Appointment of Director: Mr Andrew Denver  
 
    Annual Report  
 
    Cochlear 2006 AGM Results of Meeting  
 
    AGM Presentation to Shareholders  
 
    Chairman's Address to Shareholders  
 
    Full Year Results Analyst Presentation  
 
    F'06 Full Year Results  
 
    Financial Statements  
 
    Cochlear Board Changes  
 
    Cochlear Limited Wins Gold in New York  
 
    Cochlear announces approximately $270m order for China  
 
    Cochlear Limited Response to Share Price Increase  
 
    Half Yearly Results Analyst Presentation  
 
    F'06 Half Year Results  
 
    Financial statements